Development of an Analytical Method for Determination of Related Substances and Degradation Products of Cabotegravir Using Analytical Quality by Design Principles-Reference-Cited by-同舟云学术

Development of an Analytical Method for Determination of Related Substances and Degradation Products of Cabotegravir Using Analytical Quality by Design Principles

Published:2022-03-04 Issue:10 Volume:7 Page:8896-8905
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Kovač Lidija¹²,Časar Zdenko¹²^ORCID,Trdan Lušin Tina¹²,Roškar Robert²^ORCID

Affiliation:

1. Analytics Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, Ljubljana, SI- 1526, Slovenia

2. Faculty of Pharmacy, University of Ljubljana, Ljubljana, SI-1000, Slovenia

Funder

Sandoz

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.1c07260

Reference23 articles.

1. Cabotegravir. HIV integrase inhibitor, Anti-HIV agent

2. A literature review of the patent application publications on cabotegravir – an HIV integrase strand transfer inhibitor

3. GlaxoSmithKline Home Page. https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-first-global-regulatory-approval-of-cabenuva-the-first-complete-long-acting-regimen-for-the-treatment-of-hiv/ (accessed 2021–12–20).

4. U.S. Food and Drug Administration Home Page. https://www.fda.gov/news-events/press-announcements/fda-approves-first-extended-release-injectable-drug-regimen-adults-living-hiv (accessed 2021–12–20).

5. European Medicines Agency Home Page. https://www.ema.europa.eu/en/news/first-long-acting-injectable-antiretroviral-therapy-hiv-recommended-approval (accessed 2021–12–20).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Horizons in Antiretroviral Drug Delivery Systems for HIV Management;Current Medicinal Chemistry;2024-08-09

2. A stability‐indicating method development and validation for the determination of related substances in novel synthetic decapeptide by HPLC;Journal of Peptide Science;2024-04-30

3. Systematic optimization of reverse phase ultra‐high‐performance liquid chromatography method for quantification of nilotinib and its related substances in bulk drug and pharmaceutical formulation using quality by design approach;SEPARATION SCIENCE PLUS;2024-02-07

4. A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition in Enhancing Long-Acting Drug Delivery;Pharmaceutics;2024-01-20

5. Development and validation of RP-HPLC method for estimation of Torsemide and Spironolactone in bulk and pharmaceutical dosage forms: a quality by design approach;Journal of Chemical Metrology;2023-12-17